These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 6499925)

  • 1. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation.
    McLennan PL; Taylor DA
    Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
    Watts SW; Gilbert L; Webb RC
    Hypertension; 1995 Dec; 26(6 Pt 2):1056-9. PubMed ID: 7498967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats.
    Su C; Uruno T
    Eur J Pharmacol; 1984 Nov; 106(2):283-90. PubMed ID: 6529977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
    Morecroft I; MacLean MR
    Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.
    Conolan S; Quinn MJ; Taylor DA
    Br J Pharmacol; 1986 Sep; 89(1):129-35. PubMed ID: 3801767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.
    Taylor EM; Kaumann AJ
    Br J Pharmacol; 1994 Jan; 111(1):264-70. PubMed ID: 8012704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
    Russell A; Banes A; Berlin H; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307.
    Verdouw PD; Jennewein HM; Heiligers J; Duncker DJ; Saxena PR
    Eur J Pharmacol; 1984 Jul; 102(3-4):499-509. PubMed ID: 6548449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oxyhemoglobin on vasoconstriction in response to 5-hydroxytryptamine in isolated, perfused canine basilar arteries.
    Orz YI; Tsuji T; Aoki T; Yen Y; Chiba S; Kobayashi S
    Neurosurgery; 1998 Nov; 43(5):1176-84. PubMed ID: 9802861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
    MacLean MR; Sweeney G; Baird M; McCulloch KM; Houslay M; Morecroft I
    Br J Pharmacol; 1996 Nov; 119(5):917-30. PubMed ID: 8922741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine.
    Anwar MA; Ford WR; Broadley KJ; Herbert AA
    Br J Pharmacol; 2012 Apr; 165(7):2191-202. PubMed ID: 21958009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
    Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
    Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism by some ergot derivatives of 5-HT-induced vasoconstriction.
    Conolan S; Taylor DA
    Eur J Pharmacol; 1986 Apr; 123(2):299-302. PubMed ID: 3709667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-for myl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig coronary arteries induced by 5-HT and alpha-methylserotonin: comparison with ketanserin.
    Gong H; Rashid M; Nakamura T; Hattori K; Nakazawa M; Kihara H; Yoshimoto R; Nagatomo T
    Biol Pharm Bull; 2000 Sep; 23(9):1105-7. PubMed ID: 10993215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.